Matsukawa Yoko, Yamagishi Yuka, Mikamo Hiroshige, Sawamura Haruki, Matsubara Shigenori, Yamaoka Kazukiyo, Asano Yuko, Ishigo Shiomi, Suematsu Hiroyuki, Mutou Toshihiro, Teraji Mayumi, Hashido Hikonori, Terada Hiroshi, Saeki Hirokazu, Miyabe Takanori, Tanaka Kaori, Watanabe Kunitomo, Akita Shigeki, Okada Masako, Takemoto Yasuhiko, Sakuma Takashi
Clinical Laboratories, Gifu Prefectual Tajimi Hospital.
Jpn J Antibiot. 2010 Jun;63(3):224-41.
Since antimicrobial resistance in Streptococcus pneumoniae become serious problem, we have conducted the epidemiological analysis of Streptococcus pneumoniae in Gifu prefecture. We have investigated the mutations of penicillin-binding protein (PBP) cording genes, the mutations of macrolide-resistant cording genes, and antimicrobial susceptibility using broth microdilution method, for 345 strains isolated from clinical specimens between May 2006 and July 2006 at 12 clinical facilities of 5 medical area. The ratio of penicillin-susceptible S. pneumoniae (gPSSP), penicillin-intermediate S. pneumoniae (gPISP), and penicillin-resistant S. pneumoniae (gPRSP), which were judged by molecular techniques, were 7.2%, 53.5%, and 39.4%, respectively. Only 1 gPSSP strain was isolated from children under three years old. There have been regional differences of the isolation rate of gPRSP between Gifu/Chuno area (55-60%) and Tono/Hida area (23-32%) in second- or third-medical facilities. The isolation rate of PBP mutation genes, pbp2x, pbp1a and pbp2b, were 92.8%, 52.5% and 53.3%, respectively. The isolation rate of macrolide-resistant cording genes, mefA only, ermB only, and both mefA and ermB, were 30%, 50% and 8%, respectively. The strains of S. pneumoniae with both mefA and ermB mutations, increased from 4% in 2002 to 8% in 2006. The antimicrobial susceptibility of S. pneumoniae to penicillin G (PCG) showed two peaks around 0.03 and 1 microg/mL, and 89% of S. pneumoniae with minimum inhibitory concentration (MIC) value 1 microg/mL was gPRSP. The MIC values of PCG against 69% strains of gPRSP distributed between 0.25 and 1 microg/mL. There have been the decreased tendency for the differences among medical facilities in penicillin resistant strains. Although cefditoren showed the most effective antimicrobial activity in oral cephems tested, there have been the strains with MIC value of over 1 microg/mL. The MIC90 of panipenem was 0.125 microg/mL, which was the best antimicrobial activity in carbapenems. The resistant rates of clarithromycin and azithromycin were 85% and 84%, respectively. The strains with the gene mutation of ermB have showed resistant to clindamycin. The MIC90 of tosufloxacin was 0.25 microg/mL, which was the best antimicrobial activity in quinolones. We have detected 4 levofloxacin highly resistant S. pneumoniae, of which MIC value was over 32 microg/mL. Also, we have encountered the episode of the spread of S. pneumoniae in one family, which was clarified by scientific approach.
由于肺炎链球菌的抗菌耐药性已成为严重问题,我们对岐阜县的肺炎链球菌进行了流行病学分析。我们采用肉汤微量稀释法,对2006年5月至7月期间从5个医疗区域的12个临床机构的临床标本中分离出的345株菌株,调查了青霉素结合蛋白(PBP)编码基因的突变、大环内酯耐药编码基因的突变以及抗菌药敏情况。通过分子技术判断的青霉素敏感肺炎链球菌(gPSSP)、青霉素中介肺炎链球菌(gPISP)和青霉素耐药肺炎链球菌(gPRSP)的比例分别为7.2%、53.5%和39.4%。仅从3岁以下儿童中分离出1株gPSSP菌株。在二级或三级医疗机构中,岐阜/中浓地区(55 - 60%)和远野/飞弹地区(23 - 32%)的gPRSP分离率存在区域差异。PBP突变基因pbp2x、pbp1a和pbp2b的分离率分别为92.8%、52.5%和53.3%。大环内酯耐药编码基因仅mefA、仅ermB以及mefA和ermB两者的分离率分别为30%、50%和8%。同时具有mefA和ermB突变的肺炎链球菌菌株从2002年的4%增加到2006年的8%。肺炎链球菌对青霉素G(PCG)的抗菌药敏在0.03和1微克/毫升左右出现两个峰值,最低抑菌浓度(MIC)值为1微克/毫升的肺炎链球菌中89%为gPRSP。PCG对69%的gPRSP菌株的MIC值分布在0.25至1微克/毫升之间。青霉素耐药菌株在医疗机构之间的差异有下降趋势。尽管头孢妥仑在测试的口服头孢菌素中显示出最有效的抗菌活性,但仍有MIC值超过1微克/毫升的菌株。帕尼培南 的MIC90为0.125微克/毫升,在碳青霉烯类药物中抗菌活性最佳。克拉霉素和阿奇霉素的耐药率分别为85%和84%。具有ermB基因突变的菌株对克林霉素耐药。托氟沙星的MIC90为0.25微克/毫升,在喹诺酮类药物中抗菌活性最佳。我们检测到4株左氧氟沙星高度耐药的肺炎链球菌,其MIC值超过32微克/毫升。此外,我们还遇到了一个家庭中肺炎链球菌传播的事件,该事件通过科学方法得以查明。